Modulation of cytokine responses in sepsis (Q40841502)

24 September 2017

1 reference

title

Modulation of cytokine responses in sepsis (English)

1 reference

24 September 2017

0 references

Lowry SF

1

1 reference

PubMed ID

8363256

24 September 2017

Moldawer LL

series ordinal

2

1 reference

PubMed ID

8363256

24 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Annals of the New York Academy of Sciences

24 September 2017

1 reference

24 September 2017

685

1 reference

24 September 2017

471-482

1 reference

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

24 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Oxpentifylline in endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Preliminary report: effects of interleukin-1 on platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB35909.X

10.1111/J.1749-6632.1993.TB35909.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8363256